Crossref
journal-article
Elsevier BV
Structure (78)
References
74
Referenced
335
10.1126/science.6189183
/ Science / Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS) by Barre-Sinoussi (1983)10.1126/science.6200936
/ Science / Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS by Gallo (1984)10.1126/science.2994223
/ Science / Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene by Veronese (1985)10.1126/science.2984774
/ Science / Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients by Robey (1985)10.1126/science.2986290
/ Science / Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III by Allan (1985)10.1038/312763a0
/ Nature / The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus by Dalgleish (1984)10.1126/science.272.5263.872
/ Science / HIV-1 entry co-factor by Feng (1996)10.1038/381661a0
/ Nature / Identification of a major co-receptor for primary isolates of HIV-1 by Deng (1996)10.1016/S0092-8674(00)81313-6
/ Cell / The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates by Choe (1996)10.1038/381667a0
/ Nature / HIV-1 entry into CD4+ cells is mediatd by the chemokine receptor CC–CKR-5 by Dragic (1996)10.1126/science.272.5270.1955
/ Science / Cc CKR5 by Alkhatib (1996)10.1016/S0092-8674(00)81314-8
/ Cell / A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors by Doranz (1996)10.1016/S0092-8674(00)80205-6
/ Cell / Core structure of gp41 from the HIV envelope glycoprotein by Chan (1997)10.1038/387426a0
/ Nature / Atomic structure of the ectodomain from HIV-1 gp41 by Weissenhorn (1997)10.1038/31405
/ Nature / Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody by Kwong (1998)10.1073/pnas.97.16.9026
/ Proc. Natl. Acad. Sci. USA / Energetics of the HIV gp120–CD4 binding reaction by Myszka (2000)10.1038/31514
/ Nature / The antigenic structure of the human immunodeficiency virus gp120 envelope glycoprotein by Wyatt (1998)10.1126/science.280.5371.1884
/ Science / The HIV-1 envelope glycoproteins by Wyatt (1998)10.1126/science.286.5444.1579
/ Science / Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR by Bewley (1999)10.1038/nm1196-1244
/ Nat. Med. / The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection by Cocchi (1996)10.1093/emboj/16.10.2599
/ EMBO J. / HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor by Bieniasz (1997)10.1128/JVI.71.9.7136-7139.1997
/ J. Virol. / Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop by Speck (1997)10.1126/science.280.5371.1949
/ Science / A conserved human immunodeficiency virus gp120 glycoprotein structure involved in chemokine receptor binding by Rizzuto (1998)10.1016/S0092-8674(00)80577-2
/ Cell / Tyrosine sulfation of the amino ternimus of CCR5 facilitates HIV-1 entry by Farzan (1999)10.1128/JVI.69.1.39-48.1995
/ J. Virol. / Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera by Wrin (1995)10.1128/JVI.69.7.4413-4422.1995
/ J. Virol. / Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates by Sullivan (1995)10.1128/JVI.68.4.2253-2259.1994
/ J. Virol. / Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization by Koito (1994)10.1126/science.1636088
/ Science / Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1 by Hwang (1992)10.1089/aid.1997.13.1291
/ AIDS Res. Hum. Retroviruses / The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism by Morikita (1997)10.1128/JVI.72.8.6332-6338.1998
/ J. Virol. / Determinants of HIV-1 envelope glycoprotein activation by sCD4 and monoclonal antibodies by Sullivan (1998)10.1099/0022-1317-77-4-753
/ J. Gen. Virol. / Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1 by Schonning (1996)10.1128/JVI.74.15.6769-6776.2000
/ J. Virol. / V2 loop glycosylation of the human immunodeficiecy virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies by Ly (2000)10.1128/JVI.71.4.2779-2785.1997
/ J. Virol. / Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex by Fouts (1997){'key': '10.1016/S0969-2126(00)00547-5_BIB34', 'first-page': 'S137', 'article-title': 'The neutralizing antibody response to HIV-1', 'volume': '13A', 'author': 'Parren', 'year': '1999', 'journal-title': 'AIDS Suppl.'}
/ AIDS Suppl. / The neutralizing antibody response to HIV-1 by Parren (1999)10.1128/JVI.65.8.3973-3985.1991
/ J. Virol. / Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue by Li (1991)10.1038/nsb1295-1062
/ Nat. Struct. Biol. / Why protein crystals favour some space-groups over others by Wukovitz (1995)10.1074/jbc.274.7.4115
/ J. Biol. Chem. / Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1) by Kwong (1999)10.1107/S0021889898009686
/ J. Appl. Cryst. / Use of cryoprotectants in combination with immiscible oils for flash cooling macromolecular crystals by Kwong (1999)10.1128/JVI.74.4.1961-1972.2000
/ J. Virol. / Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus (HIV) by Kwong (2000){'key': '10.1016/S0969-2126(00)00547-5_BIB40', 'series-title': 'Profile of a quasispecies', 'author': 'Stewart', 'year': '1999'}
/ Profile of a quasispecies by Stewart (1999)10.1038/348411a0
/ Nature / Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains by Wang (1990)10.1038/348419a0
/ Nature / Crystal structure of an HIV-binding recombinant fragment of human CD4 by Ryu (1990)10.1016/S0969-2126(00)00008-3
/ Structure / Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices by Ryu (1994)10.1073/pnas.93.26.15030
/ Proc. Natl. Acad. Sci. USA / Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding by Wu (1996)10.1038/387527a0
/ Nature / Dimeric association and segmental variability in the structure of human CD4 by Wu (1997)10.1128/JVI.73.7.5294-5300.1999
/ J. Virol. / Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation by Cheng-Mayer (1999)10.1128/JVI.73.10.8873-8879.1999
/ J. Virol. / Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo by Etemad-Moghadam (1999)10.1128/JVI.72.5.3512-3519.1998
/ J. Virol. / Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity by Parren (1998)10.1128/JVI.66.1.235-243.1992
/ J. Virol. / Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein 120 retention from sCD4-sensitive isolates by Moore (1992)10.1128/JVI.68.4.2570-2577.1994
/ J. Virol. / Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1 by Kabat (1994)10.1089/08892220050042819
/ AIDS Res. Hum. Retroviruses / Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1 by Platt (2000)10.1128/JVI.71.2.873-882.1997
/ J. Virol. / CD4, CXCR-4 and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1 by Kozak (1997)10.1128/JVI.74.23.10984-10993.2000
/ J. Virol. / The level of CD4 expression limits infection of primary Rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses by Bannert (2000)10.1073/pnas.88.17.7802
/ Proc. Natl. Acad. Sci. USA / Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor by Brighty (1991)10.1146/annurev.bi.48.070179.001551
/ Ann. Rev. Biochem. / Regulation of oxygen affinity of hemoglobin by Perutz (1979)10.1089/088922299310025
/ AIDS Res. Hum. Retroviruses / Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up by Janssens (1999)10.1128/JVI.66.2.875-885.1992
/ J. Virol. / Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo after cocultivation in vitro by Kusumi (1992)10.1128/JVI.65.10.5574-5578.1991
/ J. Virol. / Molecular characterization of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual by Daniels (1991)10.1038/334444a0
/ Nature / Biologically diverse molecular variants within a single HIV-1 isolate by Fisher (1988)10.1073/pnas.97.1.79
/ Proc. Natl. Acad. Sci. USA / Interaction of poliovirus receptor with poliovirus by He (2000)10.1073/pnas.97.1.73
/ Proc. Natl. Acad. Sci. USA / Three-dimensional structure of poliovirus receptor bound to poliovirus by Belnap (2000)10.1093/emboj/18.22.6249
/ EMBO J. / Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor by Kolatkar (1999)10.1038/317145a0
/ Nature / Structure of a human common cold virus and functional relationship to other picornaviruses by Rossman (1985)10.1126/science.2994218
/ Science / Three-dimensional structure of poliovirus at 2.9 Å resolution by Hogle (1985)10.1128/JVI.68.12.8193-8201.1994
/ J. Virol. / Distribution of drug resistance mutations in type 3 poliovirus identifies three reginos involved in uncoating functions by Mosser (1994)10.1016/S0076-6879(97)76066-X
/ Methods Enymol. / Processing of X-ray diffraction data collected in oscillation mode by Otwinowski (1997)10.1107/S0907444998003254
/ Acta Crystallogr. D Biol. Crystallogr. / Crystallography & NMR system by Brunger (1998)10.1038/384179a0
/ Nature / CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 by Wu (1996)10.1107/S002188989801053X
/ J. Appl. Cryst. / A gentle vapor diffusion technique for cross-linking of protein crystals for cryocrystallography by Lusty (1999)10.1107/S0108767393007597
/ Acta Crystallogr. / AMoRe by Navaza (1994){'key': '10.1016/S0969-2126(00)00547-5_BIB71', 'series-title': 'X-PLOR Version 3.1', 'author': 'Brunger', 'year': '1992'}
/ X-PLOR Version 3.1 by Brunger (1992)10.1002/prot.340110407
/ Proteins Struct. Funct. Genet. / Protein folding and association by Nicholls (1991)10.1107/S0021889891004399
/ J. Appl. Cryst. / Molscript by Kraulis (1991)10.1107/S0108767390010224
/ Acta Crystallogr. A / Improved methods for building protein models in electron density maps and the location of errors in these models by Jones (1991)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 25, 2002, 3:49 p.m.) |
Deposited | 5 years, 7 months ago (Jan. 15, 2020, 11:18 a.m.) |
Indexed | 21 minutes ago (Sept. 2, 2025, 7:34 a.m.) |
Issued | 24 years, 9 months ago (Dec. 1, 2000) |
Published | 24 years, 9 months ago (Dec. 1, 2000) |
Published Print | 24 years, 9 months ago (Dec. 1, 2000) |
@article{Kwong_2000, title={Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates}, volume={8}, ISSN={0969-2126}, url={http://dx.doi.org/10.1016/s0969-2126(00)00547-5}, DOI={10.1016/s0969-2126(00)00547-5}, number={12}, journal={Structure}, publisher={Elsevier BV}, author={Kwong, Peter D. and Wyatt, Richard and Majeed, Shahzad and Robinson, James and Sweet, Raymond W. and Sodroski, Joseph and Hendrickson, Wayne A.}, year={2000}, month=dec, pages={1329–1339} }